Results 111 to 120 of about 23,251 (254)

Australasian chronic lymphocytic leukaemia consensus statement: 2026 update. [PDF]

open access: yesIntern Med J
McKeague S   +27 more
europepmc   +1 more source

Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma Skin Infiltration Triggered by Borrelia Burgdorferi Infection

open access: yesRomanian Journal of Laboratory Medicine, 2016
Bojan Anca   +4 more
doaj   +1 more source

PB1921: IS CHEMOIMMUNOTHERAPY (CIT) HISTORY IN THE FIRST LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA?

open access: yesHemaSphere, 2023
Catherine Parbutt   +2 more
doaj   +1 more source

Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia—Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups

open access: yesBritish Journal of Haematology, EarlyView.
Summary Most patients treated for chronic lymphocytic leukaemia (CLL) fail to achieve measurable residual disease (MRD) negativity. The role of maintenance with the immunomodulatory drug lenalidomide in these patients is unclear. A randomised multicentre phase III trial (ACTRN12610000060044) was conducted in Australia and France to assess the effect of
Thérèse Aurran‐Schleinitz   +45 more
wiley   +1 more source

Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience. [PDF]

open access: yesBr J Haematol
Duminuco A   +21 more
europepmc   +1 more source

An Unusual Presentation of Chronic Lymphocytic Leukaemia [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Kavita Paul   +3 more
doaj   +1 more source

Prospective phase I study of nivolumab to promote graft‐versus‐tumour in relapsed or refractory haematological malignancy post allogeneic haematopoietic stem cell transplantation

open access: yesBritish Journal of Haematology, EarlyView.
Baseline immunophenotype and gene expression predict suitability for salvage nivolumab in patients with relapsed/refractory haematological malignancy. Summary Allogeneic haematopoietic stem cell transplantation (alloHSCT) relies on donor‐derived T cells to mediate the graft‐versus‐tumour (GVT) effect, but relapse may result from impaired immune ...
Trung Q. Ngo   +7 more
wiley   +1 more source

Evolution of the drug sensitivity landscape of chronic lymphocytic leukaemia. [PDF]

open access: yesBr J Haematol
Hermansen JU   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy